Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the β-thalassemia syndromes. Genetic association studies have identified sequence variants in the gene BCL11A that influence HbF levels. Here, we examine BCL11A as a potential regulator of HbF expression. The high-HbF BCL11A genotype is associated with reduced BCL11A expression. Moreover, abundant expression of full-length forms of BCL11A is developmentally restricted to adult erythroid cells. Down-regulation of BCL11A expression in primary adult erythroid cells leads to robust HbF expression. Consistent with a direct role of BCL11A in globin gene regulation, we find that BCL11A occupies several discrete sites in the β-globin gene cluster. BCL11A emerges as a therapeutic target for reactivation of HbF in β-hemoglobin disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The retention of both HBG genes, each with slightly different promoter sequences, also contributes to nuanced regulatory control and may influence HbF levels in adults, a feature of clinical relevance in disorders like β-thalassemia and sickle cell disease [97].”
From Origin and Evolution of Genes in Eukaryotes: Mechanisms, Dynamics, and Functional Implications (2025) · cites this paper as [97]
In the citing paper
“Reducing bcl11a expression in transgenic sickle mice derepressed g-globin genes.17,18”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [17]
In the citing paper
“current treatments aim to induce the expression of non-mutated fetal hemoglobin (HbF), which is functional but transcriptionally repressed post-birth (Sankaran et al. 2008).”
From From serendipity to strategy: molecular glue degraders in cancer therapeutics (2025) · cites this paper as Sankaran et al. 2008
In the citing paper
“Further molecular studies revealed that BCL11A interacts with several erythroid regulators including GATA1, FOG1, and SOX6, and with the nucleosome remodeling and deacetylase complex (NuRD) (4, 6).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [4]
In the citing paper
“We identi fi ed numerous peptides of BCL11A and nearly all previously established interacting proteins, including FOG1, the entire NuRD complex, and the nuclear matrix protein MATRIN-3 (4).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [4]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Self-citationA Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma
Moffatt, M. F., Kabesch, M., Liang, L., Dixon, A. L., Strachan, D., Heath, S., Depner, M., von Berg, A., Bufe, A., Rietschel, E., et al. (2007) · Nature · doi:10.1038/nature06014 · Cited by 1,604
A HapMap harvest of insights into the genetics of common disease
Manolio, T. A., Brooks, L. D., & Collins, F. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34772 · Cited by 889
Tsai, S.-F., Martin, D. I. K., Zon, L. I., D'Andrea, A. D., Wong, G. G., & Orkin, S. H. (1989) · Nature · doi:10.1038/339446a0 · Cited by 885
Self-citationTsang, A. P., Visvader, J. E., Turner, C. A., Fujiwara, Y., Yu, C., Weiss, M. J., Crossley, M., & Orkin, S. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80318-9 · Cited by 712
Self-citationUda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V. G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711566105 · Cited by 672
Self-citationLettre, G., Sankaran, V. G., Bezerra, M. A. C., Araújo, A. S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F. F., Hirschhorn, J. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804799105 · Cited by 561
Self-citationA QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., et al. (2007) · Nature Genetics · doi:10.1038/ng2108 · Cited by 529
Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes
Göring, H. H. H., Curran, J. E., Johnson, M. P., Dyer, T. D., Charlesworth, J., Cole, S. A., Jowett, J. B. M., Abraham, L. J., Rainwater, D. L., Comuzzie, A. G., et al. (2007) · Nature Genetics · doi:10.1038/ng2119 · Cited by 504
Cited by
Items 401–500 of 1,001
Chaouch, L., Moumni, I., Ouragini, H., Darragi, I., Kalai, M., Chaouachi, D., Boudrigua, I., Hafsia, R., & Abbès, S. (2015) · Hematology · doi:10.1080/10245332.2015.1107275 · Cited by 28
Giannopoulou, E., Bartsakoulia, M., Tafrali, C., Kourakli, A., Poulas, K. A., Stavrou, E. F., Papachatzopoulou, A., Georgitsi, M., & Patrinos, G. P. (2012) · Hemoglobin · doi:10.3109/03630269.2012.717515 · Cited by 27
Cantú, I., & Philipsen, S. (2014) · Haematologica · doi:10.3324/haematol.2014.116483 · Cited by 27
Folate depletion induces erythroid differentiation through perturbation of de novo purine synthesis
Maynard, A. G., Pohl, N. K., Mueller, A., Petrova, B., Wong, A. Y. L., Wang, P., Culhane, A. J., Brook, J. R., Hirsch, L. M., Hoang, N., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj9479 · Cited by 26
Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias
Foong, W. C., Ho, J. J., Loh, C. K., & Viprakasit, V. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011579.pub2 · Cited by 26
Bhanushali, A. A., Patra, P. K., Nair, D., Verma, H. K., & Das, B. R. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.10.003 · Cited by 26
Zuccato, C., Breda, L., Salvatori, F., Breveglieri, G., Gardenghi, S., Bianchi, N., Brognara, E., Lampronti, I., Borgatti, M., Rivella, S., et al. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1430-5 · Cited by 26
Dai, Y., Sangerman, J., Luo, H., Fucharoen, S., Chui, D. H. K., Faller, D. V., & Perrine, S. P. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.10.004 · Cited by 26
Cai, T., Chen, X., Li, J., Xiang, B., Yang, L., Liu, Y., Chen, Q., He, Z., Sun, K., & Liu, P. (2017) · American Journal of Hematology · doi:10.1002/ajh.24902 · Cited by 26
Sokolova, A. O., Mararenko, A., Rozin, A., Podrumar, A. I., & Gotlieb, V. K. (2017) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2017.09.003 · Cited by 26
Li, Y., Ding, L., Li, W., Story, M. D., & Pace, B. S. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-153 · Cited by 26
What influences Hb fetal production in adulthood?
Carrocini, G. C. S., Zamaro, P. J. A., & Bonini-Domingos, C. R. (2011) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20110059 · Cited by 26
Sun, K., Huang, Y., Palanisamy, K., Chang, S., Wang, I., Wu, K., Chen, P., Peng, C., & Li, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-00150-7 · Cited by 26
Tough decoy targeting of predominant let-7 miRNA species in adult human hematopoietic cells
de Vasconcellos, J. F., Byrnes, C., Lee, Y. T., Allwardt, J. M., Kaushal, M., Rabel, A., & Miller, J. L. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1273-x · Cited by 26
Diamantidis, M. D., Ikonomou, G., Argyrakouli, I., Pantelidou, D., & Delicou, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211886 · Cited by 25
BCL11A-deficient human erythropoiesis is impaired in vitro and after xenotransplantation into mice
Jang, Y., Feng, R., Palmer, L. E., Mayuranathan, T., Yao, Y., Mayberry, K. D., Zhou, S., Xu, J., Gossett, J. M., Kang, G., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015574 · Cited by 25
Self-citationTherapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
Papizan, J. B., Porter, S. N., Sharma, A., & Pruett‐Miller, S. M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20200096 · Cited by 25
Mohammad, S. N. N. A., Iberahim, S., Rahman, W. S. W. A., Hassan, M. N., Edinur, H. A., Azlan, M., & Zulkafli, Z. B. (2022) · Diagnostics · doi:10.3390/diagnostics12061374 · Cited by 25
Peron, A., D’Arco, F., Aldinger, K. A., Smith‐Hicks, C. L., Zweier, C., Gradek, G. A., Bradbury, K., Accogli, A., Andersen, E., Au, P. Y. B., et al. (2024) · European Journal of Human Genetics · doi:10.1038/s41431-024-01701-z · Cited by 25
Demirci, S., Zeng, J., Palchaudhuri, R., Wu, C., Abraham, D. M., Hayal, T. B., Essawi, K., Nguyen, M. A., Stasula, U., Chu, R., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.10.014 · Cited by 25
A survey of well conserved families of C2H2 zinc-finger genes in Daphnia
Seetharam, A. S., Bai, Y., & Stuart, G. W. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-276 · Cited by 25
Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease
Cui, S., & Engel, J. D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-7299-9_7 · Cited by 25
Hurdles to the Adoption of Gene Therapy as a Curative Option for Transfusion-Dependent Thalassemia
Thuret, I., Ruggeri, A., Angelucci, E., & Chabannon, C. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac007 · Cited by 25
Grieco, A. J., Billett, H. H., Green, N., Driscoll, M. C., & Bouhassira, E. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129431 · Cited by 25
Single gene disorders come into focus - again
Ropers, H. (2010) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2022.12130781 · Cited by 25
Progress in Understanding the Hemoglobin Switch
Forget, B. G. (2011) · New England Journal of Medicine · doi:10.1056/nejme1106969 · Cited by 25
A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies
Zittersteijn, H. A., Harteveld, C. L., Klaver-Flores, S., Lankester, A. C., Hoeben, R. C., Staal, F. J. T., & Gonçalves, M. A. F. V. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.617780 · Cited by 24
Pathogenic BCL11A variants provide insights into the mechanisms of human fetal hemoglobin silencing
Shen, Y., Li, R., Teichert, K., Montbleau, K. E., Verboon, J. M., Voit, R. A., & Sankaran, V. G. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009835 · Cited by 24
Self-citationLessard, S., Rimmelé, P., Ling, H., Moran, K., Vieira, B. F., Lin, Y.-D., Rajani, G. M., Hong, V., Reik, A., Boismenu, R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-74716-7 · Cited by 24
Human Globin Knock-in Mice Complete Fetal-to-Adult Hemoglobin Switching in Postnatal Development
McConnell, S. C., Huo, Y., Liu, S., & Ryan, T. M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00725-10 · Cited by 24
Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System
Mussolino, C., Alzubi, J., Pennucci, V., Turchiano, G., & Cathomen, T. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.149 · Cited by 24
BCL11A Promotes the Progression of Laryngeal Squamous Cell Carcinoma
Zhou, J., Zhou, L. F., Zhang, D., Tang, W.-J., Tang, D., Shi, X., Yang, Y., Zhou, L., Liu, F., Yu, Y., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00375 · Cited by 24
Innovative Treatments for Rare Anemias
Cappellini, M. D., Marcon, A., Fattizzo, B., & Motta, I. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000576 · Cited by 24
PML4 facilitates erythroid differentiation by enhancing the transcriptional activity of GATA-1
Wu, J., Zhou, L., Yu, W., Zhao, Z., Xie, X., Wang, W., Xiong, J., Li, M., Xue, Z., Wang, X., et al. (2013) · Blood · doi:10.1182/blood-2013-02-483289 · Cited by 24
Banzon, V., Ibañez, V., Vaitkus, K., Ruiz, M. A., Peterson, K. R., DeSimone, J., & Lavelle, D. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.10.003 · Cited by 24
SIRT1 deacetylates SATB1 to facilitate MAR HS2 -MAR ε interaction and promote ε-globin expression
Xue, Z., Lv, X., Song, W., Wang, X., Zhao, G., Wang, W., Xiong, J., Mao, B., Yu, W., Yang, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks064 · Cited by 24
Genetic and Epigenetic Mechanisms of β-Globin Gene Switching
Iarovaia, O. V., Kovina, A. P., Petrova, N. V., Razin, S. V., Ioudinkova, E. S., Vassetzky, Y. S., & Ulianov, S. V. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918040090 · Cited by 24
Escudero, J. M., Haller, J. L., Clay, C. M., & Escudero, K. W. (2010) · Journal of Ovarian Research · doi:10.1186/1757-2215-3-4 · Cited by 24
GPS2 promotes erythroid differentiation by control of the stability of EKLF protein
Ma, W., Wang, X., Li, C., Tian, H.-H., Zhang, J., Bi, J., Ren, G., Tao, S., Liu, X., Zhang, W., et al. (2020) · Blood · doi:10.1182/blood.2019003867 · Cited by 23
An evolving understanding of multiple causal variants underlying genetic association signals
Long, E., Williams, J., Zhang, H., & Choi, J. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.01.018 · Cited by 23
MBD2 contributes to developmental silencing of the human ε-globin gene
Rupon, J. W., Wang, S. Z., Gnanapragasam, M. N., Labropoulos, S. V., & Ginder, G. D. (2011) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2011.01.001 · Cited by 23
Generation of a genomic reporter assay system for analysis of γ‐ and β‐globin gene regulation
Chan, K., Xu, J., Wardan, H., McColl, B., Orkin, S. H., & Vadolas, J. (2012) · The FASEB Journal · doi:10.1096/fj.11-199356 · Cited by 23
Self-citationComplex craniosynostosis is associated with the 2p15p16.1 microdeletion syndrome
Florisson, J. M. G., Mathijssen, I. M. J., Dumee, B., Hoogeboom, J. A. M., Poddighe, P. J., Oostra, B. A., Frijns, J., Koster, L., de Klein, A., Eussen, B., et al. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35632 · Cited by 23
Prakobkaew, N., Fucharoen, S., Fuchareon, G., & Siriratmanawong, N. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12201 · Cited by 23
Fluhr, S., Krombholz, C. F., Meier, A., Epting, T., Mücke, O., Plass, C., Niemeyer, C. M., & Flotho, C. (2017) · Epigenetics · doi:10.1080/15592294.2017.1356959 · Cited by 23
Roy, P., Bhattacharya, G., Mandal, A., Dasgupta, U. B., Banerjee, D., Chandra, S., & Das, M. (2012) · Hemoglobin · doi:10.3109/03630269.2012.735626 · Cited by 23
Biology of Erythropoiesis, Erythroid Differentiation, and Maturation
Papayannopoulou, T., & Migliaccio, A. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00026-3 · Cited by 23
LIN28A Expression Reduces Sickling of Cultured Human Erythrocytes
de Vasconcellos, J. F., Fasano, R. M., Lee, Y. T., Kaushal, M., Byrnes, C., Meier, E. R., Anderson, M., Rabel, A., Braylan, R. C., Stroncek, D. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106924 · Cited by 23
A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing
Zheng, G., Yin, M., Mehta, S., Chu, I.-T., Wang, S., Alshaye, A., Drainville, K., Buyanbat, A., Bienfait, F., Tenglin, K., et al. (2024) · Science · doi:10.1126/science.adp3025 · Cited by 22
Self-citationClinical application of base editing for treating β-thalassaemia
Lai, Y., Liu, R., Wang, L., Ma, X.-K., Li, Y., Yang, G., Shi, L., Guo, Y., Wei, Z., Zhou, X., et al. (2026) · Nature · doi:10.1038/s41586-026-10342-9 · Cited by 22
CRISPR/Cas9 system and its applications in human hematopoietic cells
Hu, X. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.09.003 · Cited by 22
Peslak, S. A., Khandros, E., Huang, P., Lan, X., Geronimo, C. L. A., Grevet, J. D., Abdulmalik, O. Y., Zhang, Z., Giardine, B. M., Keller, C. A., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002475 · Cited by 22
Clinical trials and promising preclinical applications of CRISPR/Cas gene editing
Çerçi, B., Uzay, İ. A., Kara, M. K., & Dinçer, P. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121204 · Cited by 22
Katta, V., O’Keefe, K., Li, Y., Mayuranathan, T., Lazzarotto, C. R., Wood, R. K., Levine, R. M., Powers, A., Mayberry, K. D., Manquen, G., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.07.022 · Cited by 22
Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia
Breda, L., Rivella, S., Zuccato, C., & Gambari, R. (2013) · Expert Review of Hematology · doi:10.1586/ehm.13.24 · Cited by 22
Gene-centric functional dissection of human genetic variation uncovers regulators of hematopoiesis
Nandakumar, S. K., McFarland, S., Mateyka, L. M., Lareau, C. A., Ulirsch, J. C., Ludwig, L. S., Agarwal, G., Engreitz, J., Przychodzen, B. P., McConkey, M. E., et al. (2019) · eLife · doi:10.7554/elife.44080 · Cited by 22
Self-citationTranslational control by heme-regulated elF2α kinase during erythropoiesis
Chen, J.-J., & Zhang, S. (2022) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000704 · Cited by 22
Lai, Y., Zhou, L., Yi, S., Chen, Y., Tang, Y., Yi, S., Yang, Z., Wei, H., Zheng, C., & he, S. T. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.01.011 · Cited by 22
SOX6 Downregulation Induces γ-Globin in Human β-Thalassemia Major Erythroid Cells
Li, J., Yongrong, L., Luo, J. P., Luo, L., Liu, R., Liu, Z., & Zhao, W. (2017) · BioMed Research International · doi:10.1155/2017/9496058 · Cited by 21
Genome-based therapeutic interventions for β-type hemoglobinopathies
Karamperis, K., Tsoumpeli, M. T., Kounelis, F., Koromina, M., Mitropoulou, C., Moutinho, C., & Patrinos, G. P. (2021) · Human Genomics · doi:10.1186/s40246-021-00329-0 · Cited by 21
Exploring epigenetic and microRNA approaches for γ-globin gene regulation
Starlard‐Davenport, A., Fitzgerald, A., & Pace, B. S. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211028195 · Cited by 22
Han, Y., Tan, X., Jin, T., Zhao, S., Li, H., Zhang, W., Kurita, R., Nakamura, Y., Liu, J., Li, D., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174788 · Cited by 21
Effective therapies for sickle cell disease: are we there yet?
Crossley, M., Christakopoulos, G. E., & Weiss, M. J. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.07.003 · Cited by 22
Bianchi, N., Cosenza, L. C., Lampronti, I., Finotti, A., Breveglieri, G., Zuccato, C., Fabbri, E., Marzaro, G., Chilin, A., Angelis, G. D., et al. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0187-2 · Cited by 21
Goodman, S. R., Pace, B. S., Hansen, K. C., D’Alessandro, A., Xia, Y., Daescu, O., & Glatt, S. J. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216640150 · Cited by 21
Changes in lncRNAs and related genes in β-thalassemia minor and β-thalassemia major
Ma, J., Liu, F., Du, X., Ma, D., & Xiong, L. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0503-1 · Cited by 21
Chen, R.-L., Chou, Y., Lan, Y., Huang, T.-S., & Shen, C. ‐. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049130 · Cited by 22
Haemoglobin and the Inherited Disorders of Globin Synthesis
Thein, S. L., & Rees, D. C. (2010) · Wiley eBooks · doi:10.1002/9781444323160.ch6 · Cited by 21
Vathipadiekal, V., Farrell, J. J., Wang, S., Edward, H. L., Shappell, H., Al‐Rubaish, A. M., Al‐Muhanna, F., Naserullah, Z., Alsuliman, A., Qutub, H. O., et al. (2016) · American Journal of Hematology · doi:10.1002/ajh.24527 · Cited by 20
The Fetal-to-Adult Hemoglobin Switch — Mechanism and Therapy
Orkin, S. H. (2025) · New England Journal of Medicine · doi:10.1056/nejmra2405260 · Cited by 21
Self-citationMusunuru, K., Bernstein, D., Cole, F. S., Khokha, M. K., Lee, F. S., Lin, S., McDonald, T. V., Moskowitz, I. P. G., Quertermous, T., Sankaran, V. G., et al. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.002178 · Cited by 20
Self-citationLiang, Y., Zhang, X., Liu, Y., Wang, L., Ye, Y., Tan, X., Pu, J., Zhang, Q., Bao, X., Wei, X., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17511 · Cited by 20
Liu, G., Kim, J., Nguyen, N. H., Zhou, L., & Dean, A. (2024) · Blood · doi:10.1182/blood.2023021287 · Cited by 20
Screening and treatment of thalassemia
Su, Y., Xie, J., He, J., Shen, Y., Li, T., Huang, W., Tong, X., & Bian, Q. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120211 · Cited by 20
Treating hemoglobinopathies using gene-correction approaches: promises and challenges
Cottle, R. N., Lee, C. M., & Bao, G. (2016) · Human Genetics · doi:10.1007/s00439-016-1696-0 · Cited by 20
Emerging therapies in β-thalassemia: toward a new era in management
Bou‐Fakhredin, R., Tabbikha, R., Daadaa, H., & Taher, A. T. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1752180 · Cited by 20
Daniels, D. E., Ferguson, D. C. J., Griffiths, R. E., Trakarnsanga, K., Cogan, N. M., MacInnes, K. A., Mordue, K. E., Andrienko, T., Vicens, I. F., Jiménez, D. R., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.06.002 · Cited by 20
Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease
Ramadier, S., Chalumeau, A., Félix, T., Othman, N., Aknoun, S., Casini, A., Maule, G., Masson, C., Cian, A. D., Frati, G., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.08.019 · Cited by 20
Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene
Mettananda, S. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.752278 · Cited by 20
3′HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression
Himadewi, P., Wang, X. Q. D., Feng, F., Gore, H., Liu, Y., Yu, L., Liu, J., Kurita, R., Nakamura, Y., Pfeifer, G., et al. (2021) · eLife · doi:10.7554/elife.70557 · Cited by 20
Huang, C., Li, Q., & Li, J. (2022) · Medical Review · doi:10.1515/mr-2022-0029 · Cited by 20
Gamage, U., Warnakulasuriya, K., Hansika, S., & Silva, G. N. (2023) · Thalassemia Reports · doi:10.3390/thalassrep13010006 · Cited by 20
Dadheech, S., MadhuLatha, D. M., Jainc, S., Joseph, J., Jyothy, A., & Munshi, A. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.184285 · Cited by 20
BCL11A Down-Regulation Induces γ-Globin in Human β-Thalassemia Major Erythroid Cells
Li, J., Yongrong, L., & Shi, L. (2018) · Hemoglobin · doi:10.1080/03630269.2018.1515774 · Cited by 20
Das, S. S., & Chakravorty, N. (2019) · Genomics · doi:10.1016/j.ygeno.2019.03.002 · Cited by 20
Chami, N., & Lettre, G. (2014) · Genes · doi:10.3390/genes5010051 · Cited by 19
Self-citationIn The Blood: Connecting Variant to Function In Human Hematopoiesis
Nandakumar, S. K., Liao, X., & Sankaran, V. G. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.05.006 · Cited by 19
Self-citationChromatin Remodeling in the Brain-a NuRDevelopmental Odyssey
Larrigan, S., Shah, S. J., Fernandes, J. A. L., & Mattar, P. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094768 · Cited by 19
Targeting fetal hemoglobin expression to treat β hemoglobinopathies
Steinberg, M. H. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2066519 · Cited by 19
Characterization of Deletions of the HBA and HBB Loci by Array Comparative Genomic Hybridization
Sabath, D. E., Bender, M. A., Sankaran, V. G., Vamos, E., Kentsis, A., Yi, H.-S., & Greisman, H. A. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.07.011 · Cited by 19
Self-citationPUM1 mediates the posttranscriptional regulation of human fetal hemoglobin
Elagooz, R., Dhara, A. R., Gott, R. M., Adams, S. E., White, R. A., Ghosh, A., Ganguly, S., Man, Y., Owusu-Ansah, A. T., Mian, O. Y., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006730 · Cited by 18
The Role of Bcl11 Transcription Factors in Neurodevelopmental Disorders
Seigfried, F. A., & Britsch, S. (2024) · Biology · doi:10.3390/biology13020126 · Cited by 18
Gene therapy and gene editing strategies in inherited blood disorders
Song, X., Liu, J., Chen, T., Zheng, T., Wang, X., & Guo, X. (2024) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.07.004 · Cited by 18
Scaffolds for Artificial miRNA Expression in Animal Cells
Calloni, R., & Bonatto, D. (2015) · Human Gene Therapy Methods · doi:10.1089/hgtb.2015.043 · Cited by 18
Lai, Y., Chen, Y., Chen, B., Zheng, H., Yi, S., Li, G., Wei, H., he, S. T., & Zheng, C. (2016) · Hemoglobin · doi:10.1080/03630269.2016.1253586 · Cited by 18
Okoh, M. P., Alli, L. A., Tolvanen, M. E. E., & Nwegbu, M. M. (2018) · Current Drug Discovery Technologies · doi:10.2174/1570163815666181002101611 · Cited by 18
The Nucleosome Remodeling and Deacetylase Complex in Development and Disease
Basta, J. M., & Rauchman, M. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800802-7.00003-4 · Cited by 18
Korenke, G. C., Schulte, B., Biskup, S., Neidhardt, J., & Owczarek‐Lipska, M. (2020) · Molecular Syndromology · doi:10.1159/000508566 · Cited by 18
Novel therapies in β‐thalassaemia
Grech, L., Borg, K., & Borg, J. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14918 · Cited by 19
Transcriptional silencing of fetal hemoglobin expression by NonO
Li, X., Chen, M., Liu, B., Lu, P., Lv, X., Zhao, X., Cui, S., Xu, P., Nakamura, Y., Kurita, R., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab671 · Cited by 18
Metadata
- Authors
- Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H.
- Affiliations
- Broad Institute (US)
- Division of Hematology/Oncology, Children's Hospital Boston, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.
- Corresponding author
- Orkin, Stuart H.
- ORCID
- Venue
- Science
- Published
- 2008-12-19
- Volume
- 322
- Issue
- 5909
- Pages
- 1839-1842
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1968165696
- Semantic Scholar
- a52e99500fd26811a2ae248d6dce95e3152b5bb7
- Cited by
- 919
- References
- 27
- Citations by year
- 2026: 59 · 2025: 46 · 2024: 55 · 2023: 52 · 2022: 47 · 2021: 73 · 2020: 70 · 2019: 31 · 2018: 50 · 2017: 59 · 2016: 63 · 2015: 46 · 2014: 45 · 2013: 53 · 2012: 49
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (HL32262-26, P01HL032262, R01HL032259, HL32259-27)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- fetal hemoglobin, BCL11A, globin gene regulation, beta-globin gene cluster, sickle cell disease, beta-thalassemia, erythroid cells, therapeutic target
- MeSH terms
- Animals, Carrier Proteins, Cells, Cultured, Erythroblasts, Erythropoiesis, Fetal Hemoglobin, Gene Expression Regulation, Multigene Family, Hemoglobinopathies, Histone Deacetylases, Humans, Nuclear Proteins, Repressor Proteins, Transcription Factors, Transcription, Genetic, Down-Regulation, Erythroid Precursor Cells, K562 Cells, Protein Isoforms, Polymorphism, Single Nucleotide, RNA Interference, Erythroid Cells, Cell Line, Tumor, GATA1 Transcription Factor, Mice, beta-Globins, gamma-Globins, Mi-2 Nucleosome Remodeling and Deacetylase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.